Frontier Medicines Adds Kevin Webster, Johannes Hermann to C-Suite - Xconomy

Frontier Medicines Adds Kevin Webster, Johannes Hermann to C-Suite  XconomyFrontier Medicines has appointed Kevin Webster to serve as the cancer drug developer's chief scientific officer. Webster most recently worked at eFFECTOR.